Achaogen (AKAO) Tops Q3 EPS by 20c

Achaogen (NASDAQ: AKAO) reported Q3 EPS of ($0.41), $0.20 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $16 million versus the consensus estimate of $8.72 million.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c